Comprehensive Analysis Of The Cell And Gene Therapy Market: Technological Evolution, Regional Demand, And Forecast Scenarios To 2034

Fortune Business Insights has announced the release of its market assessment report, "Global Cell and Gene Therapy Market Size, Share, Trends Analysis Report, by Type, Processing, Distribution Channel, Market Outlook and Industry Analysis 2034."

Fortune Business Insights Report has released its latest report on the "Cell and Gene Therapy Market Size 2026." This report provides a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR forecasts, and emerging opportunities to help companies identify growth areas and build effective strategies. Backed by data-driven insights and future outlooks, this study is a valuable resource for companies seeking to maintain their competitive edge and leverage the market's potential.

The global cell and gene therapy market is valued at US$13.17 billion in 2025 and is projected to grow from US$17.54 billion in 2026 to US$200.54 billion in 2034, representing a compound annual growth rate (CAGR) of 35.60% during the forecast period.

Get a sample PDF report : https://www.fortunebusinessinsights.com/jp/%E5%95%8F%E3%81%84%E5%90%88%E3%82%8F%E3%81%9B/%E3%83%AA%E3%82%AF%E3%82%A8%E3%82%B9%E3%83%88-%E3%82%B5%E3%83%B3%E3%83%97%E3%83%AB-pdf/114130 

Latest FDA Approval

The FDA has approved several AI-enabled medical devices essential to smart hospital infrastructure, including advanced radiology systems such as Fujifilm's ECHELON Synergy MRI and Shanghai United Influence's uMI Panvivo, to enhance diagnostic accuracy and workflow automation.

The FDA has finalized guidance on modifying AI-driven devices using Advance Change Control Plans (PCCPs) to simplify the approval process and ensure continued safety without repeated marketing applications.

The major cell and gene therapy market manufacturers featured in the market report are as follows:

Vertex Pharmaceuticals, Inc. (USA)
Crystal Biotech (USA)
Rocket Pharmaceuticals (USA)
CRISPR Therapeutics (Switzerland)
Bayer AG (Germany)
Novartis AG (Switzerland)
Gilead Sciences, Inc. (USA)
Hoffmann-La Roche Ltd. (Spark Therapeutics) (USA)
Bristol-Myers Squibb Company (USA)
Adaptimune (USA)
The rising incidence of cancer and rare genetic diseases is driving market growth by increasing demand for more selective treatments.

Market Trends

driver:

The global cell and gene therapy market is being driven by the introduction of new antibiotics and advances in surgical interventions, which together improve patient outcomes and propel market growth. The increasing risk factors such as diabetes, obesity, and immunodeficiency further contribute to the rising global incidence.

Cell and gene therapy market segmentation:

By type

Cell therapy
Types of treatment
CAR-T cell therapy
TCR-T cell therapy
Natural killer (NK) cells
others
Product Type
Kym Ria
Jesus Carta
Tekartas
Briangi
Abekuma
To travel
others
express
Oncology
others
Gene therapy
Product Type
Zolgensma
Luxtan
Loctavian
others
Vector type
Viral vector
Nonviral vectors
express
Genetic diseases
ophthalmology
hematology
others
by end user

Hospitals and Clinics
Specialized clinic
others
Research process:

The global cell and gene therapy market research report utilizes both primary and secondary data. The research process analyzes a wide range of factors influencing the industry, including government regulations, market conditions, level of competition, historical data, market status, technological advancements, future developments in related businesses, market volatility, outlook, potential barriers, and challenges.

Market regional analysis:

⇥ North America (United States, Canada, Mexico)

⇥ Europe (United Kingdom, Italy, Germany, Russia, France, Spain, Netherlands, and other European countries)

⇥ Asia Pacific region (India, Japan, China, South Korea, Australia, Indonesia, and other Asia Pacific countries)

⇥ South America (Colombia, Brazil, Argentina, and other South American countries)

⇥ Middle East and Africa (Saudi Arabia, UAE, South Africa, and other Middle Eastern and African countries)

Advantages of the report:

Chapter 1: This chapter outlines the scope of the report and provides an overview of the report by summarizing the key market segments by region, product type, and application. It provides an overview of market size, growth potential between segments, and short-term and long-term industry trends.

Chapter 2: Focusing on critical market insights, this chapter identifies the most important emerging trends driving change within the industry.

Chapter 3: This chapter details the competitive landscape among cell and gene therapy market producers, including revenue sharing, strategic moves, and recent mergers and acquisitions.

Chapter 4: Provides comprehensive profiles of key market players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 and 6 analyze the cell and gene therapy market revenue at both the regional and national levels, providing a quantitative breakdown of global market size, growth opportunities, and development prospects.

Chapter 7: Focusing on various market segments by type, this chapter examines their size and potential, guiding readers to influential and untapped market areas.

Chapter 8: We will examine segmentation by application, assess the industry's growth potential in various downstream markets, and identify promising sectors for expansion.

Chapter 9: Thoroughly review the industry's supply chain and map both upstream and downstream activities.

Chapter 10: This chapter summarizes the main findings of the report and concludes by highlighting the most important points for industry stakeholders.

table of contents

Important insights
Report Summary
Market Overview
Methodologies for Epidemiology and Market Forecasting
executive summary
Main events
Disease background and overview
Views of leading opinion leaders
Southwest
OT Analysis
Market access and redemption
appendix
Features of DelveInsight
Disclaimer
About DelveInsight
 

about us:

Fortune Business Insights™ provides accurate data and innovative business analytics to help organizations of all sizes make informed decisions. We tailor innovative solutions for our clients and help them address a variety of challenges specific to their businesses. Our goal is to empower them with holistic market intelligence by providing a detailed overview of the markets in which they operate.

inquiry:

Fortune Business Insights™ Pvt. Co., Ltd.

308, Supreme Headquarters,

Investigation number 36, banner,

Pune-Bangalore Highway,

Pune - 411045, Maharashtra, India.

Telephone:

USA: +18339092966

UK: +448085020280

Asia Pacific: +91 744 740 1245